Skip to search formSkip to main contentSkip to account menu

ACT-462206

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrrolidinesSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Entry‐into‐humans study with ACT‐462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant
A double‐blind, placebo‐ and active comparator‐controlled, randomized, single‐ascending‐dose study was conducted to investigate… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)